Skip to main content
OpenTrials
Completed

NCT Number: NCT00352170

Calcium and Vitamin D Malnutrition in Elderly Women

This study is designed to test whether calcium supplementation alone or calcium plus vitamin D reduces the incidence of fractures, reduces high parathyroid secretory activity, and halts bone loss in a population-based sample of women 55+ years of age.

* A calcium supplement of 1400 mg/d will significantly reduce the cumulative incidence of spine and appendicular fractures over four years for independently living, rural women 55 years of age and older compared to similar women on their usual diets. * A calcium supplement of 1400 mg/d plus 1100 IU vitamin D/d will significantly reduce the cumulative incidence of spine and appendicular fractures compared to a calcium supplement only.

Completed

Looking for future studies?

Notify Me

Key information

About this study

We are conducting a 4-year randomized, double-blind, placebo controlled trial of calcium or calcium with vitamin D supplementation. We randomly sampled the population of healthy, independent living women 55+ years in nine rural counties. We randomly assigned 1180 women to one of three groups: Group 1 receives calcium (1400 mg/d) and vitamin D placebo, Group 2 receives both calcium (1400 mg/d) and vitamin D (1100 IU/d) and Group 3 receives both placebos.

A full-service market research firm randomly selected telephone numbers from all households with listed numbers in the nine-county rural sample area. The firm continued calling until 1180 women were selected who met the inclusion and exclusion criteria and were willing to participate in a four year prospective study of calcium and vitamin D supplementation. The participants were enrolled into study between May 2000 and July 2001.

Participants have study visits every six months. Annually the following are performed: bone density scans, height and weight, brief medical history including medicine changes, fracture surveillance, and compliance with calcium and vitamin D. At baseline and end of study, spine x-rays and dietary recall were obtained.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy women ages 55 and older who were at least four years postmenopausal living independently in a nine-county rural area of Nebraska

-

Exclusion criteria

  • chronic kidney disease, 2) Paget's metabolic bone disease, and 3) history of cancer except for superficial basal or squamous cell carcinoma of the skin and

-

Treatment and study plan

Calcium supplementation

Dietary Supplement

calcium carbonate 1500 mg/day

calcium and vitamin D3 supplementation

Dietary Supplement

calcium carbonate 1500 mg/day vitamin D3 1000 IU/day

Placebo

Dietary Supplement

calcium and vitamin D3 placebo

Primary outcomes

  1. fractures

    Time frame: 4 years

Secondary outcomes

  1. changes in bone mass and density

    Time frame: 4 years

  2. changes in serum dihydroxyvitamin D

    Time frame: one year and four years

  3. changes in serum parathyroid hormone

    Time frame: one year and four years

  4. cancer

    Time frame: four years

  5. Falls

    Time frame: four years

Sponsors and collaborators

Lead sponsor

Creighton University

Other

Collaborators

  • GlaxoSmithKline

Registry information

Important dates

Study start
2000
Primary completion
2005
Study completion
2005
First posted
Jul 14, 2006
Registry last updated
Aug 11, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.